Doximity, Inc. (NASDAQ:DOCS) Holdings Decreased by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. decreased its holdings in shares of Doximity, Inc. (NASDAQ:DOCS) by 15.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 30,108 shares of the company’s stock after selling 5,527 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Doximity were worth $1,607,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Oppenheimer Asset Management Inc. grew its stake in Doximity by 13.1% in the fourth quarter. Oppenheimer Asset Management Inc. now owns 19,075 shares of the company’s stock valued at $1,018,000 after purchasing an additional 2,212 shares in the last quarter. Oregon Public Employees Retirement Fund grew its stake in Doximity by 2.4% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 26,100 shares of the company’s stock valued at $1,393,000 after purchasing an additional 600 shares in the last quarter. Los Angeles Capital Management LLC grew its stake in Doximity by 33.7% in the fourth quarter. Los Angeles Capital Management LLC now owns 870,322 shares of the company’s stock valued at $46,466,000 after purchasing an additional 219,448 shares in the last quarter. Amalgamated Bank grew its stake in Doximity by 2.3% in the fourth quarter. Amalgamated Bank now owns 60,742 shares of the company’s stock valued at $3,243,000 after purchasing an additional 1,343 shares in the last quarter. Finally, IFP Advisors Inc grew its stake in Doximity by 344.1% in the fourth quarter. IFP Advisors Inc now owns 1,328 shares of the company’s stock valued at $71,000 after purchasing an additional 1,029 shares in the last quarter. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Doximity Stock Down 3.2 %

Doximity stock opened at $68.22 on Tuesday. The business has a 50 day moving average price of $62.11 and a two-hundred day moving average price of $50.95. The stock has a market cap of $12.74 billion, a price-to-earnings ratio of 68.22, a price-to-earnings-growth ratio of 4.10 and a beta of 1.39. Doximity, Inc. has a 12 month low of $22.96 and a 12 month high of $85.21.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the company. Wells Fargo & Company restated an “equal weight” rating on shares of Doximity in a research note on Friday, February 7th. Canaccord Genuity Group boosted their price target on Doximity from $60.00 to $71.00 and gave the stock a “hold” rating in a research report on Friday, February 7th. Canaccord Genuity Group cut Doximity from a “buy” rating to a “hold” rating and boosted their price target for the stock from $40.00 to $60.00 in a research report on Wednesday, November 13th. The Goldman Sachs Group boosted their price target on Doximity from $58.00 to $80.00 and gave the stock a “neutral” rating in a research report on Monday, February 10th. Finally, Piper Sandler raised Doximity from a “neutral” rating to an “overweight” rating and boosted their price target for the stock from $31.00 to $78.00 in a research report on Friday, February 7th. Eleven investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $64.22.

Insider Buying and Selling at Doximity

In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of the company’s stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the transaction, the director now owns 6,360 shares of the company’s stock, valued at $366,463.20. This represents a 75.87 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 37.40% of the company’s stock.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.